A review on Pharmacological and Phytochemical properties of Luffa echinata

Registration ID: IJNRD_184734

Published ID: IJNRD2303001

: Click Here to Get

Sonal H. Kanani, Dr. Devang J Pandya

Devadali, Cytotoxic, Cucurbitacine, Cucurbitaceae, TNBC, Pharmacological

Background: Plants are the source of a variety of important secondary metabolites with pharmacological and pharmacognostic consequences that have the potential to become future "super medicines." The biotic and abiotic stressors have an impact on how these metabolites are produced in vivo, which causes a steady build-up of different phytochemicals. and their derivatives, which can help create and develop future medications. The current study's goal is to review the occurrence of potentially useful pharmacological and pharmacognostic secondary metabolites considering the possible uses of the understudied Ayurvedic medicinal plant species Luffa echinata inventing and creating pharmaceuticals for the future. Main body of the abstract: Luffa echinata, a member of the Cucurbitaceae family, is a rich source of phytochemicals for therapeutic use, including Cucurbitacine B, Cucurbitacine E, Eletarin-2-glycoside, Beta-sterol glycoside, Chrysirol, Echinatin, Apigenin, Luteolin, Luteolin-7-glycoside, Datiscacin, Oleanolic acid. These substances all or some of which have anti-cancer, antioxidant, antimicrobial, antibacterial, antiviral, analgesic, anti-inflammatory, antidepressant, anxiolytic, antiepileptic, hepatoprotective, antifungal, and antiulcer activity. Short Conclusion: alkaloids, carbohydrates, proteins, glycosides, flavonoids, sterols, triterpenes, flavones, reducing sugars, and tannins. Potent bioactive compounds like CuB, eletarin (CuE), eletarin-2-glucoside, isocucurbitacin B, β-sitosterol, echinatol-A, and -B, chrysirol-7-glucoside, chrysirol-7-epiglucoside, echinatol A, echinatol B, echinatin have been reported from the fruits. Datiscacin (cucurbitin-20-acetate) found in Luffa echinata that have the potential to replace conventional drugs as therapeutic agents. Its uses may be attributed to important classes of phytochemicals present in it; a bitter compound known to have antitumor activity has been reported from L. echinata. Similarly, flavonoids (luteolin-7-glucoside and chrysoeriol-7-glucoside), triterpenes, fatty acids, and saponin (gypsogennin) have been also isolated from seeds. The present chapter gives a detailed review of Luffa echinata chiefly from its pharmacognostic, phytochemical, and utility perspectives.

Published Paper   E-Certificate

Sonal H. Kanani & Dr. Devang J Pandya (March-2023). A review on Pharmacological and Phytochemical properties of Luffa echinata . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(3), a1-a11. https://ijnrd.org/papers/IJNRD2303001.pdf

Volume 8 Issue 3, March-2023

Pages : a1-a11

Paper Reg. ID: IJNRD_184734

Published Paper Id: IJNRD2303001

Downloads: 000121998

Research Area: Pharmacy

Author Type: Indian Author

Country: Rajkot, GUJARAT, INDIA

Published Paper PDF: https://ijnrd.org/papers/IJNRD2303001.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2303001

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details